Dolby (DLB) Form 144 Notice — 25,000 Shares via Morgan Stanley ($1.81M)

Rhea-AI Filing Summary

Dolby Laboratories (DLB) Form 144 shows a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney on 08/12/2025 with an aggregate market value of $1,807,827.50. The filing lists 95,844,185 shares outstanding, and the securities were acquired the same day by stock option exercise with payment in cash. The notice also records multiple recent sales by Yeaman Family Trust between 06/10/2025 and 07/16/2025 in several tranches. By signing, the seller represents they are not aware of any undisclosed material adverse information; a Rule 10b5-1 plan date is not indicated.

Insights

Financial Analyst

TL;DR Insider/related-party sales are noted but the proposed 25,000-share sale is small versus total outstanding shares.

The filing discloses a planned sale of 25,000 shares valued at $1.81M executed through Morgan Stanley on 08/12/2025 and securities acquired that same day via stock option exercise paid in cash. The company’s outstanding share count is reported as 95,844,185, making the single proposed transaction a very small fraction of total equity. Multiple prior sales by Yeaman Family Trust across June–July 2025 are recorded, indicating ongoing disposition activity by that account. From a financial-materiality perspective, these volumes are unlikely to move valuation but are relevant for share supply monitoring and insider activity transparency.

Corporate Governance Expert

TL;DR The notice is a routine Rule 144 disclosure; it includes the standard insider representation about material nonpublic information.

The Form 144 contains expected elements: broker details (Morgan Stanley Smith Barney), acquisition method (stock option exercise), payment in cash, and a signed representation that the seller does not possess undisclosed material adverse information. There is mention of Rule 10b5-1 but no plan adoption date is provided on the form. Governance-wise, the filing meets disclosure requirements by listing recent related sales and the proposed sale, supporting market transparency without revealing additional governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	1807827.50	95844185	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Stock Option Exercise	ISSUER			25000	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	07/16/2025	2491	186825.00
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	07/15/2025	25000	1867167.50
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	07/15/2025	14875	1116120.34
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	06/24/2025	25000	1850530.00
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	06/10/2025	25000	1905650.00
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	06/10/2025	8683	661828.68

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the DLB Form 144 propose to sell?

The filing proposes to sell 25,000 shares of common stock through Morgan Stanley Smith Barney on 08/12/2025 with aggregate market value $1,807,827.50.

How were the securities acquired for the proposed sale in the DLB filing?

The securities were acquired on 08/12/2025 via a stock option exercise from the issuer and paid for in cash.

What recent sales by related parties are disclosed in the Form 144?

The filing lists multiple sales by Yeaman Family Trust between 06/10/2025 and 07/16/2025, including tranches of 25,000, 14,875, 8,683, and 2,491 shares with corresponding gross proceeds shown for each transaction.

Does the filer state they possess any material nonpublic information?

By signing the notice, the person represents they do not know of any material adverse information

Is a Rule 10b5-1 trading plan date provided in the DLB Form 144?

No specific plan adoption or instruction date